Beyond NB, MYCN amplification is also observed in pediatric brain tumors, including pediatric high-grade gliomas (pHGGs) and MBs with SHH, Group 3, and Group 4 subtypes [98,99]. This evidence concerns the gene MYCN and brain neoplasm.